Nifedipine Dosing Recommendations
For adults with hypertension or angina, use extended-release nifedipine 30-90 mg once daily as first-line, with titration up to 180 mg daily for angina if needed; avoid immediate-release formulations unless combined with beta-blockers due to serious cardiovascular risks. 1
Adult Dosing by Indication
Hypertension
- Start at 30 mg once daily of extended-release formulation and titrate upward based on response 1
- Allow at least 4 weeks between dose adjustments to observe full therapeutic effect 1
- Maximum dose: 120 mg daily for standard hypertension management 1
- For resistant hypertension, doses up to 180 mg daily may be used 1
- Most patients require combination therapy; use submaximal doses of two drugs rather than maximal doses of a single agent to minimize side effects 1
Angina
- Extended-release: 30-180 mg once daily (preferred formulation) 1, 2
- Immediate-release: 30-90 mg daily divided into multiple doses, only with concomitant beta-blockade 1, 2
- Higher doses up to 180 mg daily may be required for adequate angina control 1
Critical Safety Warning for Immediate-Release Formulations
Immediate-release nifedipine capsules should not be prescribed due to safety concerns with precipitous blood pressure drops that can cause myocardial infarction. 1 The American College of Cardiology explicitly contraindicates immediate-release nifedipine for unstable angina/NSTEMI unless given with beta-blockade 1, 3, 2. Sublingual or rapid administration can cause uncontrolled hypotension leading to end-organ damage 1.
Pediatric Dosing
Hypertension (Ages 6-17 Years)
- Extended-release: up to 120 mg per day (approximately 3 mg/kg/day) 1
- Administer once daily or twice daily to maintain consistent plasma concentrations 1
Pulmonary Hypertension
- Starting dose: 0.1-0.2 mg/kg orally three times daily 1
- Dose range: 2-3 mg/kg/day 1
- Maximum: 180 mg/day (adult dose ceiling) 1
- Note: Only 10-15% of pediatric patients with pulmonary arterial hypertension will have a positive acute vasoreactive response to calcium channel blockers 1
Special Population Considerations
Elderly Patients
- Initiate at 30 mg once daily of extended-release formulation 1
- Monitor closely for hypotension, dizziness, and falls due to decreased baroreceptor response 1
- Dihydropyridine calcium antagonists like nifedipine are particularly indicated for isolated systolic hypertension in the elderly 1
Pregnancy
- Avoid immediate-release nifedipine unless no alternative antihypertensive agents are available 1
- Never combine with magnesium sulfate due to risk of uncontrolled hypotension and fetal compromise 1
- Methyldopa remains first-line for hypertension in pregnancy 1
- If nifedipine is used, therapeutic doses range from 10-30 mg orally every 6-8 hours 4
Patients with Cardiac Dysfunction
- Avoid all calcium channel blockers in severe left ventricular dysfunction or pulmonary edema 1, 2
- Contraindicated in advanced aortic stenosis 1
- For mild left ventricular dysfunction, amlodipine and felodipine are better tolerated than nifedipine 2
Formulation-Specific Considerations
Extended-Release vs Immediate-Release
- Extended-release maintains therapeutic levels for approximately 24 hours with once-daily dosing, providing more consistent plasma concentrations and better adherence 1
- Immediate-release requires multiple daily doses; 120 mg liquid would need division throughout the day to approximate steady levels of a single 120 mg XL tablet 1
- Pharmacokinetic differences between ER formulations can include 20-25% differences in drug exposure, which may impact blood pressure control when switching formulations 3, 2
For Patients Unable to Swallow Tablets
- Consider alternative calcium channel blockers available in liquid formulations rather than immediate-release nifedipine liquid 1
Combination Therapy
- Nifedipine combines effectively with beta-blockers or ACE inhibitors for enhanced blood pressure control 1
- Combination therapy allows use of submaximal doses with larger blood pressure responses and fewer side effects 1
Common Pitfalls to Avoid
- Never use immediate-release nifedipine for acute hypertensive emergencies; use intravenous nicardipine instead 1
- Do not use sublingual administration due to unpredictable and potentially dangerous blood pressure drops 1
- Avoid switching between extended-release formulations without monitoring, as bioavailability differences may affect control 3, 2
- Do not exceed 180 mg daily for any indication 1